An Evaluation of Proportion of Patients Currently Treated with HMG-GA Reductase Inhibitors Treated to Target

Posted on Posted in Completed Project

Study Objective:
The purpose of this study was to determine the proportion of patients achieving recommended target lipid levels in a group of community-dwelling patients who were prescribed HMG-CoA Reductase inhibitors (“statins”).

Principal Investigator:
Tsuyuki RT

Co-Investigator:
Olson K

Status:
Completed

Abstract:
1. Olson KL, Tsuyuki RT. A Community-based, Cross-sectional Evaluation of Patients; Achievement of Cholesterol Targets, Presented: Canadian Cardiovascular Society 53rd Annual Meeting, Vancouver, October 29-November 1, 2000. Published: Can J Cardiol 2000;16(Suppl F):203F. Presented: American College of Clinical Pharmacy, Los Angeles, November 8, 2000. Published: Pharmacother 2000;20(10):1232.

2. Olson KL, Tsuyuki RT. Cholesterol Risk Management: A Systematic Examination of the Gap from Evidence to Practice. Published: Pharmacotherapy 2001;21(7):807–817. (link)